You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 8 No. 3, May-Jun 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Brief Communication
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Reconstructive Facial Surgery
 •Pediatrics
 •Congenital Malformations
 •Drug Therapy
 •Alert me on articles by topic

Botulinum Toxin to Improve Results in Cleft Lip Repair

Arch Facial Plast Surg. 2006;8:221-222.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Traditionally, cleft lip deformities are repaired when the infant reaches about age 3 months. Many surgeons may delay repair in certain cases of severely wide clefts to allow for presurgical preparations such as nasoalveolar molding, lip taping, and, less commonly, lip adhesion procedures.

Repair of cleft lip deformities requires meticulous attention to recreating the 3-dimensional characteristics of the lip and nasal structures by reestablishing the muscular continuity of the orbicularis oris to achieve a functional and aesthetically pleasing upper lip contour.1 One of the many factors influencing the final result of the cleft lip repair is the amount of wound tension present during healing. Creating too much tension when closing a widely separated cleft lip may result in unacceptable scars and, although rare, wound breakdown (fistula or a dehiscence).

The use of botulinum toxin to minimize facial scarring has been described by Sherris and Gassner2 and Gassner et al3 as . . . [Full Text of this Article]

METHODS

RESULTS

COMMENT

AUTHOR INFORMATION

Travis T. Tollefson, MD; Craig M. Senders, MD; Jonathan M. Sykes, MD; Paul J. Byorth, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.